Depreciation of OptiNose, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
OptiNose, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • OptiNose, Inc. Depreciation for the quarter ending 31 Mar 2025 was $64,000, a 23% decline year-over-year.
  • OptiNose, Inc. Depreciation for the twelve months ending 31 Mar 2025 was $262,000, a 36% decline year-over-year.
  • OptiNose, Inc. annual Depreciation for 2024 was $281,000, a 30% decline from 2023.
  • OptiNose, Inc. annual Depreciation for 2023 was $400,000, a 25% decline from 2022.
  • OptiNose, Inc. annual Depreciation for 2022 was $530,000, a 18% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

OptiNose, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $262,000 $64,000 -$19,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $281,000 $50,000 -$104,000 -68% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $385,000 $65,000 -$37,000 -36% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $422,000 $83,000 +$11,000 +15% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $411,000 $83,000 +$11,000 +15% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $400,000 $154,000 +$23,000 +18% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $377,000 $102,000 -$42,000 -29% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $419,000 $72,000 -$65,000 -47% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $484,000 $72,000 -$46,000 -39% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $530,000 $131,000 -$38,000 -22% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $568,000 $144,000 -$9,000 -5.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $577,000 $137,000 +$18,000 +15% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $559,000 $118,000 -$86,000 -42% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $645,000 $169,000 -$250,000 -60% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $895,000 $153,000 -$320,000 -68% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $1,215,000 $119,000 -$135,000 -53% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,350,000 $204,000 -$104,000 -34% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,454,000 $419,000 +$190,000 +83% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $1,264,000 $473,000 +$187,000 +65% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $1,077,000 $254,000 -$68,000 -21% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,145,000 $308,000 +$39,000 +14% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $1,106,000 $229,000 +$19,000 +9% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q3 2019 $1,087,000 $286,000 +$133,000 +87% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $954,000 $322,000 +$306,000 +1912% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $648,000 $269,000 +$113,000 +72% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $535,000 $210,000 +$149,000 +244% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $386,000 $153,000 +$116,000 +314% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $270,000 $16,000 -$18,000 -53% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $288,000 $156,000 +$124,000 +388% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $164,000 $61,000 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $37,000 +$20,000 +118% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $34,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $32,000 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q3 2016 $17,000 01 Jul 2016 30 Sep 2016 10-Q 27 Nov 2017 2017 Q3

OptiNose, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $281,000 -$119,000 -30% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $400,000 -$130,000 -25% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $530,000 -$115,000 -18% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $645,000 -$809,000 -56% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $1,454,000 +$348,000 +31% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $1,106,000 +$571,000 +107% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
2018 $535,000 +$371,000 +226% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $164,000 +$81,000 +98% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $83,000 +$8,000 +11% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 $75,000 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.